Le Lézard
Classified in: Environment, Health
Subjects: SVY, ENI

airPHX Validates Technology for Eliminating Pathogens on Surfaces in Health Care Facilities


MCLEAN, Va., Nov. 14, 2017 /PRNewswire/ -- airPHX ("air fix") announces independent research confirming the effectiveness of airPHX technology in eliminating three common healthcare-associated infection (HAI) pathogens.  The research, conducted by Rick Falkenberg, Ph.D with Scientific Air Solutions and published September 13, 2017, demonstrates over 4-log reductions in 30 minutes of treatment in bacterial populations of Clostridium difficile, Methicillin Resistant Staphylococcus aureus (mRSA) and Pseudomonas aeruginosa on three common contact surfaces: stainless steel, plastic (PVC) and linoleum (floor tile).  Each bacterial population exhibited in excess of 5-log reductions in organisms in 2 hours of treatment.  The research can be reviewed at https://www.airPHXhealth.com/blog

Effective on both airborne and surface pathogens, airPHX technology provides continuous infection control for the health care industry.  Using a proprietary application of atmospheric cold plasma, airPHX offers a cost-effective alternative to existing infection control protocols.  Scalable and affordable... airPHX has been proven effective on 30 common HAI pathogens including bacteria, viruses and protozoa.

Antimicrobial resistant pathogens pose an ongoing challenge to hospitals because they cause HAIs during clinical treatment of patients. Existing methods to address this challenge include sanitizers/disinfectants and deployment of UV-C technology. Both solutions have limitations and neither solution provides ongoing protection between treatments.

airPHX technology operates continuously in the background as a prophylaxis with no labor costs and minimal operating expenses.  airPHX uses a proprietary atmospheric cold plasma technology to create and distribute a low-level, unique spectrum of reactive oxygen species (ROS).  The ROS operate as an oxidizer of pathogens in a treatment space, persistently eliminating airborne and surface pathogens in the air and on all surfaces exposed to ambient air. 

According to Dr. Falkenberg: "the technology developed by airPHX has a wide range of applications due to its ability to produce a highly oxidative environment within a reaction chamber and discharge molecules that have an oxidizing capacity at levels that are safe for human exposure into the environment."  

airPHX technology has previously been commercialized for large facilities in food safety applications. Adapting the technology for the health care industry was a natural progression.  Deployed in hospitals, medical device storage, senior care, athletic facilities and other health facilities, airPHX technology provides immediate and continuing infection control at low capital and operating costs.

For complete information on the airPHX system and research results, please visit: www.airPHXhealth.com.

About airPHX | HEALTH

airPHX is a private company offering air and surface sanitization solutions. It is known for its cost-effective and innovative technology that delivers results without the usage of chemicals or UV radiation.

SOURCE airPHX


These press releases may also interest you

at 18:55
ZYUS Life Sciences Corporation ("ZYUS" or the "Company") is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May...

at 18:42
George Weston Limited ("Weston" or the "Company") today announced that all of the nominee directors listed in its management proxy circular dated March 19, 2024, were elected as directors of the Company. The vote was conducted at the Company's...

at 18:41
Family Source Consultants, LLC, a leading provider of surrogacy, egg donation, and all third-party reproduction services, is excited to announce the grand opening of its new state-of-the-art office dedicated to enhancing the journeys of intended...

at 18:15
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2024 financial results before the opening of the U.S. financial markets on Tuesday, May 14, 2024....

at 18:00
In recognition of Mother's Day on May 12th, Denny's Canada is delighted to announce that they have partnered with Women's Health Collective Canada (WHCC) to host a special fundraiser. From May 7th to 12th, in participating stores across Canada, $2...

at 17:41
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the publication in JAMA Cardiology of two-year echocardiographic data from its REDUCE LAP-HF II randomized clinical trial of the Corvia® Atrial...



News published on and distributed by: